Literature DB >> 17245762

Adaptation and evaluation of the Randox full-range CRP assay on the Olympus AU2700.

A M Dupuy1, A L Michon, S Badiou, J P Cristol.   

Abstract

The implementation of a high-sensitivity CRP (hs-CRP) assay as a routine laboratory parameter may be necessary. A single CRP method that could yield reliable results for the whole concentration range (0.1-200 mg/L) would be the most practical solution for the laboratory setting. The aim of this study was to assess the Randox full-range CRP assay on the Olympus AU2700 biochemistry analyzer and evaluate its analytical performance on serum and heparin plasma samples. The Randox CRP turbidimetric assay was compared with the existing CRP assay used routinely on the Olympus AU2700. The analytical performance of the Randox CRP with both Olympus CRP reagents (CRP for normal application and hs-CRP) was good. We found that the Randox CRP method in the range of 0.5-160 mg/L was closely correlated to the Olympus CRP and hs-CRP for serum samples. According to a Bland-Altman analysis, the serum and heparinized samples showed an excellent agreement in CRP concentrations throughout the entire range (mean difference = -0.035 +/- 1.806 mg/L) as well as in CRP levels <10 mg/L. Our data indicate that Randox full-range CRP measurements using an immunoturbidimetry assay on Olympus systems perform as well for routine diagnostics as other high-sensitivity applications using serum or heparin plasma. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245762      PMCID: PMC6649145          DOI: 10.1002/jcla.20160

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 3.  High-sensitivity C-reactive protein: clinical importance.

Authors:  Shari S Bassuk; Nader Rifai; Paul M Ridker
Journal:  Curr Probl Cardiol       Date:  2004-08       Impact factor: 5.200

4.  Immunoturbidimetric determination of C-reactive protein (CRP) and high-sensitivity CRP on heparin plasma. Comparison with serum determination.

Authors:  Anne Marie Dupuy; Stéphanie Badiou; Bernard Descomps; Jean Paul Cristol
Journal:  Clin Chem Lab Med       Date:  2003-07       Impact factor: 3.694

5.  Analysis of method comparison studies.

Authors:  S Hollis
Journal:  Ann Clin Biochem       Date:  1996-01       Impact factor: 2.057

Review 6.  High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease.

Authors:  N Rifai; P M Ridker
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

7.  Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2.

Authors:  W L Roberts; L Moulton; T C Law; G Farrow; M Cooper-Anderson; J Savory; N Rifai
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

8.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

Authors:  P M Ridker; J E Buring; J Shih; M Matias; C H Hennekens
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

Review 9.  C-reactive Protein.

Authors:  Steven Black; Irving Kushner; David Samols
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

10.  C-reactive protein and bacterial infection in preterm infants.

Authors:  A Wasunna; A Whitelaw; R Gallimore; P N Hawkins; M B Pepys
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.